These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 26576481)

  • 1. Evidence that hepatitis B virus replication in mouse cells is limited by the lack of a host cell dependency factor.
    Lempp FA; Mutz P; Lipps C; Wirth D; Bartenschlager R; Urban S
    J Hepatol; 2016 Mar; 64(3):556-64. PubMed ID: 26576481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium taurocholate cotransporting polypeptide is the limiting host factor of hepatitis B virus infection in macaque and pig hepatocytes.
    Lempp FA; Wiedtke E; Qu B; Roques P; Chemin I; Vondran FWR; Le Grand R; Grimm D; Urban S
    Hepatology; 2017 Sep; 66(3):703-716. PubMed ID: 28195359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes.
    Ni Y; Lempp FA; Mehrle S; Nkongolo S; Kaufman C; Fälth M; Stindt J; Königer C; Nassal M; Kubitz R; Sültmann H; Urban S
    Gastroenterology; 2014 Apr; 146(4):1070-83. PubMed ID: 24361467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP.
    Iwamoto M; Watashi K; Tsukuda S; Aly HH; Fukasawa M; Fujimoto A; Suzuki R; Aizaki H; Ito T; Koiwai O; Kusuhara H; Wakita T
    Biochem Biophys Res Commun; 2014 Jan; 443(3):808-13. PubMed ID: 24342612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HBV life cycle is restricted in mouse hepatocytes expressing human NTCP.
    Li H; Zhuang Q; Wang Y; Zhang T; Zhao J; Zhang Y; Zhang J; Lin Y; Yuan Q; Xia N; Han J
    Cell Mol Immunol; 2014 Mar; 11(2):175-83. PubMed ID: 24509445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B Virus Infection of a Mouse Hepatic Cell Line Reconstituted with Human Sodium Taurocholate Cotransporting Polypeptide.
    Lempp FA; Qu B; Wang YX; Urban S
    J Virol; 2016 May; 90(9):4827-4831. PubMed ID: 26865711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unusual Features of Sodium Taurocholate Cotransporting Polypeptide as a Hepatitis B Virus Receptor.
    Li J; Zong L; Sureau C; Barker L; Wands JR; Tong S
    J Virol; 2016 Sep; 90(18):8302-13. PubMed ID: 27384660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocytic expression of human sodium-taurocholate cotransporting polypeptide enables hepatitis B virus infection of macaques.
    Burwitz BJ; Wettengel JM; Mück-Häusl MA; Ringelhan M; Ko C; Festag MM; Hammond KB; Northrup M; Bimber BN; Jacob T; Reed JS; Norris R; Park B; Moller-Tank S; Esser K; Greene JM; Wu HL; Abdulhaqq S; Webb G; Sutton WF; Klug A; Swanson T; Legasse AW; Vu TQ; Asokan A; Haigwood NL; Protzer U; Sacha JB
    Nat Commun; 2017 Dec; 8(1):2146. PubMed ID: 29247188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Woodchuck sodium taurocholate cotransporting polypeptide supports low-level hepatitis B and D virus entry.
    Fu L; Hu H; Liu Y; Jing Z; Li W
    Virology; 2017 May; 505():1-11. PubMed ID: 28213271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Robust Human and Murine Hepatocyte Culture Models of Hepatitis B Virus Infection and Replication.
    Qiao L; Sui J; Luo G
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30232184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis D Virus Infection of Mice Expressing Human Sodium Taurocholate Co-transporting Polypeptide.
    He W; Ren B; Mao F; Jing Z; Li Y; Liu Y; Peng B; Yan H; Qi Y; Sun Y; Guo JT; Sui J; Wang F; Li W
    PLoS Pathog; 2015 Apr; 11(4):e1004840. PubMed ID: 25902143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of Three Amino Acids in Sodium Taurocholate Cotransporting Polypeptide Renders Mice Susceptible to Infection with Hepatitis D Virus In Vivo.
    He W; Cao Z; Mao F; Ren B; Li Y; Li D; Li H; Peng B; Yan H; Qi Y; Sun Y; Wang F; Sui J; Li W
    J Virol; 2016 Oct; 90(19):8866-74. PubMed ID: 27466423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation of retinoic acid receptor diminishes hepatocyte permissiveness to hepatitis B virus infection through modulation of sodium taurocholate cotransporting polypeptide (NTCP) expression.
    Tsukuda S; Watashi K; Iwamoto M; Suzuki R; Aizaki H; Okada M; Sugiyama M; Kojima S; Tanaka Y; Mizokami M; Li J; Tong S; Wakita T
    J Biol Chem; 2015 Feb; 290(9):5673-84. PubMed ID: 25550158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NTCP opens the door for hepatitis B virus infection.
    Yan H; Liu Y; Sui J; Li W
    Antiviral Res; 2015 Sep; 121():24-30. PubMed ID: 26071008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide.
    Yan H; Peng B; Liu Y; Xu G; He W; Ren B; Jing Z; Sui J; Li W
    J Virol; 2014 Mar; 88(6):3273-84. PubMed ID: 24390325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular determinants of hepatitis B and D virus entry restriction in mouse sodium taurocholate cotransporting polypeptide.
    Yan H; Peng B; He W; Zhong G; Qi Y; Ren B; Gao Z; Jing Z; Song M; Xu G; Sui J; Li W
    J Virol; 2013 Jul; 87(14):7977-91. PubMed ID: 23678176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human induced pluripotent stem cell-derived hepatic cell lines as a new model for host interaction with hepatitis B virus.
    Kaneko S; Kakinuma S; Asahina Y; Kamiya A; Miyoshi M; Tsunoda T; Nitta S; Asano Y; Nagata H; Otani S; Kawai-Kitahata F; Murakawa M; Itsui Y; Nakagawa M; Azuma S; Nakauchi H; Nishitsuji H; Ujino S; Shimotohno K; Iwamoto M; Watashi K; Wakita T; Watanabe M
    Sci Rep; 2016 Jul; 6():29358. PubMed ID: 27386799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor.
    Nkongolo S; Ni Y; Lempp FA; Kaufman C; Lindner T; Esser-Nobis K; Lohmann V; Mier W; Mehrle S; Urban S
    J Hepatol; 2014 Apr; 60(4):723-31. PubMed ID: 24295872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of FDA approved therapeutics with hNTCP metabolic inhibitory properties to impair the HDV lifecycle.
    Blanchet M; Sureau C; Labonté P
    Antiviral Res; 2014 Jun; 106():111-5. PubMed ID: 24717262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical assessment of antiviral combination therapy in a genetically humanized mouse model for hepatitis delta virus infection.
    Winer BY; Shirvani-Dastgerdi E; Bram Y; Sellau J; Low BE; Johnson H; Huang T; Hrebikova G; Heller B; Sharon Y; Giersch K; Gerges S; Seneca K; Pais MA; Frankel AS; Chiriboga L; Cullen J; Nahass RG; Lutgehetmann M; Toettcher JE; Wiles MV; Schwartz RE; Ploss A
    Sci Transl Med; 2018 Jun; 10(447):. PubMed ID: 29950446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.